874 filings
Page 9 of 44
DEFA14A
ymw58l6fs2tp
13 May 21
Additional proxy soliciting materials
5:20pm
8-K
l2h2ozsooeyy6 ir1mv
13 May 21
Biolase Reports 70% Revenue Growth
4:11pm
DEFA14A
dlup4q39qfkae5r8uea
4 May 21
Additional proxy soliciting materials
12:00am
8-K
hb5t z8ss3zvcw14
25 Mar 21
Biolase Reports 31% Sequential Revenue Growth
12:00am
8-K
xymeyq68b8yfvwzr6n
25 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
pwgqmoufqp0d2qlg6
17 Mar 21
Departure of Directors or Certain Officers
4:15pm
8-K
way1fwe
2 Mar 21
Entry into a Material Definitive Agreement
4:15pm
8-K
qll3puuplp b0gcft2r
23 Feb 21
Departure of Directors or Certain Officers
7:33am
8-K
3sne6t
10 Feb 21
BIOLASE, Inc. Announces Pricing of $14.4 Million Bought Deal Offering
4:05pm
424B5
hio1e 2ifnho3
9 Feb 21
Prospectus supplement for primary offering
5:00pm
DEFA14A
qn7l4bdptar4bo
4 Feb 21
Additional proxy soliciting materials
5:15pm
8-K
yjipsjd
4 Feb 21
Biolase Regains Compliance with Nasdaq Minimum Bid Price Requirement and Cancels Special Meeting of Stockholders
5:13pm
DEFA14A
fcbpjw8ty0uph
3 Feb 21
Additional proxy soliciting materials
6:02am
DEFA14A
s1rg3npo8b
1 Feb 21
Additional proxy soliciting materials
6:06am
DEFR14A
m55qext
26 Jan 21
Revised proxy
6:04am
8-K
k33nfou1q h5vi
22 Jan 21
Submission of Matters to a Vote of Security Holders
4:22pm
424B3
w9r7i
15 Dec 20
Prospectus supplement
11:47am